Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Skye Bioscience Inc (OP: SKYE ) N/A UNCHANGED Last Price Updated: 3:57 PM EDT, Apr 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Skye Bioscience Inc < Previous 1 2 Next > Skye Bioscience And 2 Other Penny Stocks Insiders Are Buying February 05, 2024 The Dow Jones index closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... Via Benzinga Topics Stocks Exposures US Equities Cannabis Stock Gainers And Losers From August 25, 2023 August 25, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Marijuana Stock Movers For August 23, 2023 August 23, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From August 24, 2023 August 24, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Skye Secures $17M And Acquires Novel Phase 2-Ready Cannabinoid 1 Receptor Inhibitor August 21, 2023 Skye Bioscience, Inc. (OTCQB: SKYE) has undertaken a strategic initiative that expands the company's resources and technologies focused on developing therapeutic products focused on the endocannabinoid... Via Benzinga Marijuana Stock Movers For August 22, 2023 August 22, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Movers For August 18, 2023 August 18, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers August 07, 2023 Via Benzinga Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers August 17, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Movers For July 21, 2023 July 21, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 16, 2023 August 16, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Skye Completes Production Of Cannabinoid Based Drug In Preparation For Glaucoma Clinical Trial July 06, 2023 Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma and ocular hypertension, announced that its contract... Via Benzinga Cannabis Stock Gainers And Losers From August 14, 2023 August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Short Volatility Alert: Skye Bioscience April 19, 2023 On Tuesday, shares of Skye Bioscience (OTC: SKYE) experienced volatile short activity. After the activity, the stock price went up +3.03% to $0.017. The overall sentiment for SKYE has been Bullish. Via Benzinga Cannabis Stock Gainers And Losers From August 11, 2023 August 11, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Ethics Committee Approves Starting Multiple Ascending Dose Arm Of Phase 1 Study Of Cannabinoid Based Drug For Treatment Of Glaucoma March 15, 2023 Skye Bioscience, Inc. Via Benzinga Marijuana Stock Movers For August 8, 2023 August 08, 2023 Via Benzinga Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It March 09, 2023 Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease. Via Benzinga Marijuana Stock Movers For August 2, 2023 August 02, 2023 Via Benzinga SOL Global Reduces Principal Amount Of Credit Facility From $50M To $4.52M, Announces Management Changes February 27, 2023 SOL Global Investments Corp. (OTCQB: SKYE) (CSE:SOL) (FSE:9SB) announced that it is up to date on all interest payments and has repaid an additional $1.0 million towards its $50 million credit facility... Via Benzinga Skye Receives Positive Safety Review Of Cannabinoid Based Drug For Treatment Of Glaucoma After Second Cohort Of Phase 1 Study February 24, 2023 Skye Bioscience, Inc. (OTCQB: SKYE), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has received a positive recommendation following a... Via Benzinga Marijuana Stock Movers For August 1, 2023 August 01, 2023 Via Benzinga Skye One Step Closer To Phase 2 Clinical Trial For Cannabinoid Based Drug For Treatment Of Glaucoma January 27, 2023 Skye Bioscience, Inc. (OTCQB: SKYE) a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reported that its phase 2 clinical trial protocol has received... Via Benzinga Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants December 22, 2022 This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE). Via Benzinga Marijuana Stock Movers For July 31, 2023 July 31, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 28, 2023 July 28, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 26, 2023 July 26, 2023 Via Benzinga Cannabis Stock Movers For July 24, 2023 July 24, 2023 Via Benzinga Cannabis Stock Movers For July 20, 2023 July 20, 2023 Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.